Article Information
History
- September 29, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Rolando Pajon, Ph.D.*,1,
- Yamuna D. Paila, Ph.D.1,
- Bethany Girard, Ph.D1,
- Groves Dixon, Ph.D1,
- Katherine Kacena, Ph.D1,
- Lindsey R. Baden, M.D.2,
- Hana M. El Sahly, M.D.3,
- Brandon Essink, M.D.4,
- Kathleen M Mullane, D.O.5,
- Ian Frank, M.D.6,
- Douglas Denhan, D.O.7,
- Edward Kerwin, M.D.8,
- Xiaoping Zhao, M.S.1,
- Baoyu Ding, M.S.1,
- Weiping Deng, Ph.D1,
- Joanne E Tomassini, Ph.D1,
- Honghong Zhou, Ph.D1,
- Brett Leav, M.D.1,
- Florian Schödel, M.D., PhD1 and
- on behalf of the mRNA-1273 COVE Trial Team
- 1Moderna, Inc.
- 2Brigham and Women’s Hospital
- 3Baylor College of Medicine
- 4Meridian Clinical Research
- 5University of Chicago
- 6University of Pennsylvania
- 7Clinical Trials of Texas
- 8Criscor Clinical Research Institute
- ↵*Corresponding author Rolando Pajon, Ph.D., Director, Clinical Assays and Biomarkers, Moderna, Inc., 200 Technology Square, Cambridge, MA 02139, Phone: (617) 803-6627, Email: rolando.pajon{at}modernatx.com